A potent multivalent vaccine for modulation of immune system in atherosclerosis: an in silico approach.
- Author:
Ahmad KARKHAH
1
;
Jafar AMANI
Author Information
- Publication Type:Original Article
- Keywords: Atherosclerosis; Vaccine; HSP60; Apolipoprotein B-100; Beta 2-glycoprotein I
- MeSH: Apolipoprotein B-100; Arteries; Atherosclerosis*; Autoantigens; B-Lymphocytes; beta 2-Glycoprotein I; Chaperonin 60; Cholesterol; Computational Biology; Computer Simulation*; Epitopes; Humans; Immune System*; Immunity, Cellular; Lipoproteins; Lipoproteins, LDL; T-Lymphocytes; Vaccines
- From:Clinical and Experimental Vaccine Research 2016;5(1):50-59
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: Atherosclerosis is classically defined as an immune-mediated disease characterized by accumulation of low-density lipoprotein cholesterol over intima in medium sized and large arteries. Recent studies have demonstrated that both innate and adaptive immune responses are involved in atherosclerosis. In addition, experimental and human models have recognized many autoantigens in pathophysiology of this disease. Oxidized low-density lipoproteins, beta2 glycoprotein I (beta-2-GPI), and heat shock protein 60 (HSP60) are the best studied of them which can represent promising approach to design worthwhile vaccines for modulation of atherosclerosis. MATERIALS AND METHODS: In silico approaches are the best tools for design and evaluation of the vaccines before initiating the experimental study. In this study, we identified immunogenic epitopes of HSP60, ApoB-100, and beta-2-GPI as major antigens to construct a chimeric protein through bioinformatics tools. Additionally, we have evaluated physico-chemical properties, structures, stability, MHC binding properties, humoral and cellular immune responses, and allergenicity of this chimeric protein by means of bioinformatics tools and servers. RESULTS: Validation results indicated that 89.1% residues locate in favorite or additional allowed region of Ramachandran plot. Also, based on Ramachandran plot analysis this protein could be classified as a stable fusion protein. In addition, the epitopes in the chimeric protein had strong potential to induce both the B-cell and T-cell mediated immune responses. CONCLUSION: Our results supported that this chimeric vaccine could be effectively utilized as a multivalent vaccine for prevention and modulation of atherosclerosis.
